IRIS UniCatt

Cassano, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.597
NA - Nord America 3.584
AS - Asia 1.289
SA - Sud America 259
AF - Africa 47
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.549
DE - Germania 1.405
SE - Svezia 616
SG - Singapore 455
CN - Cina 436
IT - Italia 348
PL - Polonia 303
BR - Brasile 238
FR - Francia 184
GB - Regno Unito 165
IE - Irlanda 138
UA - Ucraina 138
IN - India 116
ID - Indonesia 84
FI - Finlandia 72
RU - Federazione Russa 68
TR - Turchia 45
BE - Belgio 37
CI - Costa d'Avorio 36
VN - Vietnam 29
HK - Hong Kong 25
IR - Iran 24
AT - Austria 21
CA - Canada 18
NL - Olanda 16
CZ - Repubblica Ceca 14
KR - Corea 13
LT - Lituania 11
CH - Svizzera 10
ES - Italia 10
JP - Giappone 9
MX - Messico 9
IQ - Iraq 8
RO - Romania 8
AR - Argentina 7
LU - Lussemburgo 7
BD - Bangladesh 6
PK - Pakistan 6
EC - Ecuador 5
PT - Portogallo 5
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
NO - Norvegia 4
ZA - Sudafrica 4
CL - Cile 3
CO - Colombia 3
EU - Europa 3
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
GE - Georgia 2
KW - Kuwait 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PE - Perù 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
CM - Camerun 1
CR - Costa Rica 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.786
Salva come PNG Salva come JPEG
Città #
Chandler 775
Singapore 295
Warsaw 284
Ashburn 252
Fairfield 171
Dublin 137
Wilmington 122
San Mateo 119
Ann Arbor 116
Jacksonville 97
New York 96
Nürnberg 91
Woodbridge 91
Houston 85
Jakarta 83
Nanjing 83
Seattle 72
Cattolica 66
Boston 64
Cambridge 58
Princeton 55
Dearborn 52
Redmond 48
Milan 45
Hyderabad 44
Moscow 44
Rome 43
Los Angeles 41
Marseille 41
Chicago 39
Abidjan 36
Beijing 36
Brussels 36
Helsinki 36
Izmir 36
The Dalles 36
Frankfurt am Main 35
Nanchang 32
London 29
Redwood City 28
Munich 27
Boardman 26
Bremen 26
Lawrence 25
Falls Church 23
Shanghai 22
Hong Kong 19
Leawood 19
Norwalk 19
Augusta 18
Mountain View 18
Hefei 16
São Paulo 16
Hebei 15
Düsseldorf 14
Kraków 14
Nuremberg 14
Dong Ket 13
Hangzhou 13
Changsha 12
Kish 12
Jiaxing 11
Lancaster 11
Seoul 11
Vienna 11
Guangzhou 10
Paris 10
San Diego 10
Santa Clara 10
Shenyang 10
Tianjin 10
Andover 9
Fremont 9
Kunming 9
North Bergen 8
Roubaix 8
Zhengzhou 8
Belo Horizonte 7
Bologna 7
Brasília 7
Brooklyn 7
Council Bluffs 7
Lauterbourg 7
Portsmouth 7
Rio de Janeiro 7
Simi Valley 7
Zurich 7
Berlin 6
Busto Arsizio 6
Costa Mesa 6
Detroit 6
Ho Chi Minh City 6
Prague 6
San Francisco 6
Toronto 6
University Park 6
Washington 6
Amsterdam 5
Brno 5
Changchun 5
Totale 4.630
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 354
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 317
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 289
Pembrolizumab as first-line treatment for metastatic uveal melanoma 284
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 263
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 216
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 212
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 190
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 179
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 169
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 163
[Gastrointestinal stromal tumors] 153
Thymoma in patients with MG: characteristics and long-term outcome 149
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 141
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 139
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 139
PDGFRA-mutant syndrome 139
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 138
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 138
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 135
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 119
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 117
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 116
Are TKIs favourable for the elderly with non-small-cell lung cancer? 114
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 111
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 110
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 109
[Gastrointestinal stromal tumors] 102
Advanced colon cancer: staging and prognosis by CEA test 97
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 95
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 95
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 92
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 92
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 91
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 91
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 89
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study) 89
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 88
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 85
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 84
eComment. Iterative metastasectomy for recurrent pulmonary disease from colorectal cancer: A challenging issue 84
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 83
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 83
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 83
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 82
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 82
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 81
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 81
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 81
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 79
Divergent gastrointestinal stromal tumors in syndromic settings 78
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 78
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 76
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 74
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 72
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 70
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 70
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 69
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 69
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 68
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 68
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 68
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 66
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 66
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 65
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 63
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 61
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 60
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 59
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 58
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 58
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 57
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 57
Primary cardiac synovial sarcoma: A review correlating outcomes with surgery and adjuvant therapy 53
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 52
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 51
Oral Health Status in Patients with Head and Neck Cancer before Radiotherapy: Baseline Description of an Observational Prospective Study 50
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 46
Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. 45
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 45
Osteoradionecrosis incidence in pre‐radiation teeth extractions: A prospective study 42
Clinical outcomes of teeth adjacent to the site of mandibulotomy or mandibulectomy in patients with head and neck cancer: results from a multidisciplinary mono-institutional head and neck tumor board 42
In reply to the letter to the editor regarding "Clinical outcomes of teeth adjacent to the site of mandibulotomy or mandibulectomy in patients with head and neck cancer: results from a multidisciplinary mono-institutional head and neck tumor board" 37
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study) 36
Authors' reply “Osteoradionecrosis incidence in preradiation teeth extractions: A prospective study” 35
Triple positive breast cancer: A distinct subtype? 35
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 32
Targeted therapy in advanced gastric carcinoma: The future is beginning 32
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 24
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study 18
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 7
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 6
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 4
Totale 8.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 0 0 0 0 0 67
2020/2021771 33 108 55 51 86 46 87 19 85 69 105 27
2021/2022965 79 45 21 111 60 40 22 149 52 59 127 200
2022/20231.960 268 274 145 338 96 229 98 187 194 38 66 27
2023/2024778 31 219 31 32 29 119 50 39 13 32 85 98
2024/20251.644 36 65 136 98 150 65 46 99 234 213 325 177
Totale 8.934